CpG-loaded multifunctional cationic nanohydrogel particles as self-adjuvanting glycopeptide antitumor vaccines.
about
Immunological Evaluation of Recent MUC1 Glycopeptide Cancer VaccinespH-degradable imidazoquinoline-ligated nanogels for lymph node-focused immune activation.Not just for tumor targeting: unmet medical needs and opportunities for nanomedicine.In Vivo Gene-Silencing in Fibrotic Liver by siRNA-Loaded Cationic Nanohydrogel Particles.Harnessing the potential of noninvasive in vivo preclinical imaging of the immune system: challenges and prospects.Cell membrane-derived nanomaterials for biomedical applications.Cationic Nanohydrogel Particles for Therapeutic Oligonucleotide Delivery.Core/shell protein-reactive nanogels via a combination of RAFT polymerization and vinyl sulfone postmodification.Reductive Decationizable Block Copolymers for Stimuli-Responsive mRNA Delivery.Self-Assembled Nano-Immunostimulant for Synergistic Immune Activation.A Synthetic MUC1 Anticancer Vaccine Containing Mannose Ligands for Targeting Macrophages and Dendritic Cells.Immunogenicity of a Fully Synthetic MUC1 Glycopeptide Antitumor Vaccine Enhanced by Poly(I:C) as a TLR3-Activating Adjuvant.Treg cells as potential cellular targets for functionalized nanoparticles in cancer therapy.Targeting cells of the immune system: mannosylated HPMA-LMA block-copolymer micelles for targeting of dendritic cells.Multi-component self-assembled anti-tumor nano-vaccines based on MUC1 glycopeptides.Nanoparticles and the immune system: challenges and opportunities.Time-resolved structural evolution during the collapse of responsive hydrogels: The microgel-to-particle transition.
P2860
Q26740513-450A073B-B0D1-4ACA-A39D-8BF95B22287DQ37126646-D0CD0EFE-55AF-49EB-99B3-963FD66AAFA6Q38602136-8C544A5F-9675-4CFD-B229-2F641F14AC74Q38815162-C9D8B5F8-1D53-4D9B-A072-55E94D2FAA68Q38821253-312E2D8C-D7DE-4993-8BF0-2E9B350615F7Q39178313-9B4147EA-FB2C-473E-968A-466C7C1F3900Q39366778-8FE3436C-D9EE-4857-A08F-64E037AF0531Q41654079-97B49326-CCA5-4268-A843-BCCFA41530B6Q42811744-AE6BD9B5-ED0F-4044-9072-A033ED72669AQ48761437-0B5907FD-4502-4E4F-97B3-814CCFA47913Q49377125-CD81AE9B-BC6D-45F7-88D1-542ACD7BE9B4Q51036586-3AE3389B-3096-4643-93F2-9974EB7F5F09Q51799863-9B0940C2-4E7C-42BF-9902-1453E4EAD9D4Q53028262-8BCCE317-AC85-4AC1-8CBC-0709FDCC585DQ53093803-6AC0B1DB-6C50-4B58-9DE6-F22C9C8120A1Q53798346-8B342658-57D1-4143-A729-032D23237FC4Q55096446-96BE1187-33F0-474F-ACB2-157BA59325C3
P2860
CpG-loaded multifunctional cationic nanohydrogel particles as self-adjuvanting glycopeptide antitumor vaccines.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
CpG-loaded multifunctional cat ...... ycopeptide antitumor vaccines.
@en
type
label
CpG-loaded multifunctional cat ...... ycopeptide antitumor vaccines.
@en
prefLabel
CpG-loaded multifunctional cat ...... ycopeptide antitumor vaccines.
@en
P2093
P2860
P356
P1476
CpG-loaded multifunctional cat ...... ycopeptide antitumor vaccines.
@en
P2093
Bastian Gerlitzki
Björn Palitzsch
Edgar Schmitt
Horst Kunz
Markus Glaffig
Natascha Stergiou
Rudolf Zentel
Sebastian Hartmann
P2860
P304
P356
10.1002/ADHM.201400460
P50
P577
2014-10-18T00:00:00Z